共 180 条
[1]
Choy EH(1997)Drag treatment of rheumatic diseases in the 1990s: achievements and future developments Drugs 53 337-48
[2]
Scott DL(1993)Antirheumatic drags: a proposed new classification [editorial] Arthritis Rheum 36 336-9
[3]
Edmonds JP(1998)Recommendations for the registration of drags used in the treatment of rheumatoid arthritis Br J Rheumatol 37 211-5
[4]
Scott DL(1998)Xenobiotic immunosuppressive agents: therapeutic effects in animal models of autoimmune diseases Scrip 2387 19-90
[5]
Furst DE(1999)Leflunomide, a new, promising agent in maintenance of remission in Wegeners granulomatosis (WG) [abstract] Scrip 2471 22-7
[6]
Burkhardt H(1999)Immunomodulation of rat antigen-induced arthritis by leflunomide alone and in combination with cyclosporin A Scrip 2485 22-70
[7]
Kalden JR(1997)Suppression of autoimmune responses and inflammatory events by leflunomide in an animal model for rheumatoid arthritis Rheumatol Int 17 85-91
[8]
Metzler C(1998)Leflunomide inhibits pyrimidine Clin Exp Immunol 112 56-80
[9]
Löw-Friedrich I(1996) synthesis in mitogen-stimulated T-lymphocytes from healthy humans Inflamm Res 45 103-9
[10]
Reinhold-Keller E(1994)A novel mechanism of action of the immunomodulatory drug, leflunomide: augmentation of the immunosuppressive cytokine, TGF-β1, and suppression of the immunostimulatory cytokine, IL-2 Agents Actions 41 C267-5